Abstract
The relationship between aspirin use and colorectal cancer risk was examined by a case-control study in Italy. Regular aspirin use was reported by only 47 (3.5%) cases and 77 (4.1%) control subjects, giving a multivariate odds ratio (OR) of 0.7 (95% CI 0.5-1.0) after allowance for education, physical exercise and selected dietary factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
La Vecchia, C., Negri, E., Franceschi, S. et al. Aspirin and colorectal cancer. Br J Cancer 76, 675–677 (1997). https://doi.org/10.1038/bjc.1997.444
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.444
This article is cited by
-
Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
BMC Cancer (2018)
-
The Impact of GWAS Findings on Cancer Etiology and Prevention
Current Epidemiology Reports (2014)
-
Prevention by Aspirin of Colorectal Adenoma Recurrence: Some Advances and Latest Results of the APACC Trial
Current Colorectal Cancer Reports (2011)
-
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Nature Reviews Cancer (2006)
-
COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States)
Cancer Causes & Control (2006)
